Clearmind Medicine Inc. SEC filings CMND
Clearmind Medicine Inc. has 372 filings in SEC EDGAR's recent list, going back to Dec 23, 2021. Its latest annual report, Form 20-F, was filed on Jan 20, 2026 for the period ended Oct 31, 2025. The most recent current report (Form 6-K) was filed on Oct 27, 2026. The company's fiscal year ends on October 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 18, 2026 | — |
| EFFECT | Filing | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 6, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Mar 30, 2026 | — |
| EFFECT | Filing | Feb 26, 2026 | — |
| CORRESP | Letter to the SEC | Feb 25, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| EFFECT | Filing | Jan 30, 2026 | — |
| EFFECT | Filing | Dec 9, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 30, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2025 | — |
| EFFECT | Filing | Sep 19, 2025 | — |
| EFFECT | Filing | Jun 18, 2025 | — |
| EFFECT | Filing | Mar 17, 2025 | — |
| EFFECT | Filing | Feb 18, 2025 | — |
| EFFECT | Filing | Sep 30, 2024 | — |
| EFFECT | Filing | Jul 30, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 1, 2024 | — |
| EFFECT | Filing | Mar 22, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2024 | — |
| EFFECT | Filing | Feb 16, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| D | Filing | Feb 7, 2024 | — |
| EFFECT | Filing | Jan 19, 2024 | — |
| EFFECT | Filing | Dec 26, 2023 | — |
| CORRESP | Letter to the SEC | Dec 26, 2023 | — |
| EFFECT | Filing | Sep 14, 2023 | — |
| CORRESP | Letter to the SEC | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 6, 2023 | — |
| CORRESP | Letter to the SEC | Sep 5, 2023 | — |
| CORRESP | Letter to the SEC | Jul 27, 2023 | — |
| CORRESP | Letter to the SEC | Jul 25, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2023 | — |
| EFFECT | Filing | Apr 3, 2023 | — |
| CORRESP | Letter to the SEC | Mar 28, 2023 | — |
| CORRESP | Letter to the SEC | Mar 27, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2023 | — |
| DRS | Filing | Feb 21, 2023 | — |
| CERT | Filing | Nov 15, 2022 | — |
| EFFECT | Filing | Nov 14, 2022 | — |
| CORRESP | Letter to the SEC | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 9, 2022 | — |
| 8-A12B | For registration of certain classes | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 9, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2022 | — |
| CORRESP | Letter to the SEC | Nov 3, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 2, 2022 | — |
| CORRESP | Letter to the SEC | Nov 1, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 31, 2022 | — |
| CORRESP | Letter to the SEC | Oct 26, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2022 | — |
| CORRESP | Letter to the SEC | Oct 20, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 6, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| CORRESP | Letter to the SEC | Sep 20, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2022 | — |
| CORRESP | Letter to the SEC | Aug 18, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2022 | — |
| CORRESP | Letter to the SEC | Jun 29, 2022 | — |
| CORRESP | Letter to the SEC | Jun 29, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 21, 2022 | — |
| DRSLTR | Filing | Jun 10, 2022 | — |
| DRS/A | Filing | Jun 10, 2022 | — |
| UPLOAD | Letter from the SEC | May 24, 2022 | — |
| DRSLTR | Filing | Apr 27, 2022 | — |
| DRS/A | Filing | Apr 27, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2022 | — |
| DRS | Filing | Dec 27, 2021 | — |
| DRSLTR | Filing | Dec 23, 2021 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMND (Nasdaq)
- Fiscal year ends
- October 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Vancouver, British Columbia, Canada (Federal Level)
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1892500
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.